Updated: January 26, 2026
How Does Fosfomycin Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Summarize with AI
How does fosfomycin (Monurol) kill bacteria? Learn how this unique UTI antibiotic's mechanism of action makes it effective even against drug-resistant infections.
Fosfomycin is one of the most mechanistically distinct antibiotics in clinical use today. Unlike other antibiotics that inhibit protein synthesis, disrupt cell membranes, or damage DNA, fosfomycin targets the very first step in bacterial cell wall construction — a step unique in the class of antibiotics that target it. Understanding how it works helps explain why it remains effective against bacteria that have become resistant to many other drugs.
Why Bacteria Need Cell Walls
All bacteria (with a few exceptions) are surrounded by a rigid cell wall made of a material called peptidoglycan. This wall serves as structural armor — without it, the bacteria's internal pressure causes it to burst and die. This is why cell wall synthesis is such a critical target for antibiotics: destroy the wall-building machinery and you destroy the bacteria.
Penicillin and all beta-lactam antibiotics (amoxicillin, cephalexin, etc.) also target cell wall synthesis — but they block a different, later step than fosfomycin. This is why bacteria that have become resistant to penicillins are often still susceptible to fosfomycin.
Fosfomycin's Target: The MurA Enzyme
Fosfomycin works by permanently disabling an enzyme called MurA (UDP-N-acetylglucosamine enolpyruvyl transferase). MurA is responsible for catalyzing the very first step in building the peptidoglycan cell wall — converting a precursor molecule (UDP-N-acetylglucosamine, or UDP-GlcNAc) into the building block the wall is made from.
In plain English: fosfomycin jams the very first brick-making machine bacteria use to build their walls. Without that first brick, no wall can be built.
How Fosfomycin Enters Bacterial Cells
Fosfomycin cannot work from the outside — it needs to get inside the bacterial cell to reach its target. It does this by "tricking" bacteria into transporting it inside. Bacteria use specific transport proteins (glycerophosphate transporter and hexose phosphate transporter) to bring nutrients into the cell. Fosfomycin mimics the shape of these nutrients closely enough that the transporters carry it inside.
Once inside, fosfomycin binds irreversibly to MurA — permanently inactivating it. Because this binding is covalent (a very strong chemical bond), the enzyme can't be repaired. The bacteria either die or stop reproducing.
Why Fosfomycin Works Against Drug-Resistant Bacteria
Antimicrobial resistance is a growing global crisis. Bacteria have evolved resistance mechanisms against almost every antibiotic class — beta-lactamases that destroy penicillins, efflux pumps that eject fluoroquinolones, and altered targets that prevent TMP-SMX from working. But fosfomycin's target (MurA) and its mechanism are so different that these existing resistance mechanisms generally don't apply to it.
This is why fosfomycin often retains activity against:
ESBL-producing E. coli: Bacteria producing extended-spectrum beta-lactamases that destroy most penicillin and cephalosporin antibiotics
MDR Enterobacterales: Multi-drug resistant gut bacteria like Klebsiella pneumoniae
Vancomycin-resistant Enterococci (VRE): Bacteria resistant to the last-resort antibiotic vancomycin
MRSA (methicillin-resistant Staphylococcus aureus): Bacteria resistant to most beta-lactam antibiotics (though fosfomycin is not typically first-line for MRSA)
Why Fosfomycin Concentrates in the Urine
After a single oral 3g dose, fosfomycin is absorbed into the bloodstream and then filtered almost entirely into the urine by the kidneys — unchanged. This means urinary concentrations of fosfomycin are extremely high (typically 1,000+ mcg/mL), far exceeding the minimum inhibitory concentrations (MIC) required to kill most UTI-causing bacteria.
This concentration in the urine is exactly what you want for treating a bladder infection. The drug targets the site of infection directly with therapeutic levels maintained for 24-48 hours from a single dose.
The Bottom Line: Why Fosfomycin's Mechanism Matters
Fosfomycin's unique mechanism — targeting MurA, with no cross-resistance to other antibiotic classes — explains why it remains useful in an era of growing antibiotic resistance. For a UTI patient, it means that even if previous antibiotics have failed due to resistance, fosfomycin may still work. If your prescription has been hard to locate at a nearby pharmacy, medfinder can help you find it. For full prescribing details, see: What Is Fosfomycin? Uses, Dosage, and What You Need to Know
Frequently Asked Questions
Fosfomycin inhibits the bacterial enzyme MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), which catalyzes the very first step in bacterial peptidoglycan cell wall synthesis. By permanently inactivating this enzyme, fosfomycin prevents bacteria from building their cell walls, causing bacterial death. This mechanism is unique among currently marketed antibiotics.
Because fosfomycin targets a completely different enzyme than all other antibiotic classes, the resistance mechanisms bacteria have evolved against penicillins, cephalosporins, fluoroquinolones, and sulfonamides do not affect fosfomycin. There is no known cross-resistance between fosfomycin and other antibiotic classes.
Fosfomycin is bactericidal — meaning it kills bacteria outright rather than just slowing their growth. It does this by irreversibly binding to and permanently inactivating the MurA enzyme, which bacteria cannot repair or replace quickly enough to survive.
After a 3g oral dose, fosfomycin reaches extremely high concentrations in the urine (often 1,000+ mcg/mL) that are maintained for 24-48 hours — far above the levels needed to kill E. coli and other common UTI pathogens. This prolonged urinary exposure from a single dose is sufficient to eradicate an uncomplicated bladder infection.
Fosfomycin resistance can develop, primarily through mutations in the bacterial transport proteins that carry fosfomycin into the cell, or through enzymatic inactivation via plasmid-mediated enzymes (particularly in Klebsiella). However, resistance rates remain relatively low in E. coli, especially compared to fluoroquinolones and TMP-SMX. This is why fosfomycin is often spared for resistant infections and shouldn't be used indiscriminately.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Fosfomycin also looked for:
More about Fosfomycin
32,900 have already found their meds with Medfinder.
Start your search today.





